iCAD Corp (ICAD) - Cumulative Company Assets

Corporate emblem and logo of iCAD, Inc. (ICAD)

iCAD, Inc. (ICAD) develops AI tools to combat oncology. The market trend visualized in monetary format on GURU.Markets, which stands at 39.95, highlights the impact of geopolitical conflicts on component logistics and patent protection. The business relies on cloud services with high customer loyalty, although equipment procurement is limited by center budgets. Management aims to implement breast cancer diagnostics in clinics via a subscription system.

ICAD: iCAD, Inc. Aggregate Company Assets 07/04/2022 - 08/02/2025

Analytical breakdowns for icadmed.com (ICAD)

- price and consensus price forecast:
Share Price iCAD|ICAD - Analyst Consensus Forecast
- market capitalization data:
Market Valuation iCAD, Inc.|ICAD - Enterprise Value
- book capitalization data:
Book Value per Share iCAD|ICAD - Company Book Value|Capitalization to Book Value Ratio icadmed.com|ICAD - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio iCAD, Inc.|ICAD - Long-Term Debt to Capital|Current Liabilities to Capital iCAD|ICAD - Company Debts|Debt to Net Assets Ratio iCAD, Inc.|ICAD - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings iCAD
Analysis of all company metrics:ICAD, iCAD Corp
Manufactured product of iCAD, Inc.

To isolate the fundamental stability of iCAD, Inc. (ICAD) from market noise, the sum of liabilities and equity is reverse-calculated via ROA, allowing for an assessment of the business's real resource potential. Analyzing fluctuations in total capital and liabilities reveals hidden tail-risk drawdown, particularly as geopolitical fragmentation and medical data sovereignty limit the expansion of AI cancer diagnostic systems.

Competitors of iCAD, Inc. (ICAD)

beigene.com (ONC) - Total Business Assets|Company Total Assets HALO|Cumulative Company Assets Revolution Medicines Inc|Company Total Assets AAPG|Company Total Assets CGON (CG Oncology Therapeutics)|URGN - Aggregate Company Assets|Total Business Assets bicara.com BCAX|PSNL: Company Total Assets|ERAS - Cumulative Company Assets|Company Total Assets DCTH|YMAB (Y-mAbs Corp) - Company Assets|AURA - Aggregate Company Assets|Aggregate Asset Value Candel (CADL)|Accuray (ARAY) - Cumulative Company Assets|Aggregate Asset Value sellaslifesciences.com (SLS)|Actuate Therapeutics, Inc - Company Total Assets|CTOR - Cumulative Company Assets|TuHURA - Cumulative Company Assets|TARA: Company Total Assets|Aggregate Company Assets Fate Therapeutics FATE|Aadi Bioscience (WHWK) - Aggregate Asset Value|Company Total Assets TCRX (TScan Therapeutics Inc)|Company Assets Champions Oncology Corp|XBIT (XBiotech Inc.) - Company Total Assets|Company Total Asset Base cel-sci.com (CVM)|OS Therapies - Company Total Assets|Cumulative Company Assets radiopharmtheranostics.com RADX|Artiva - Company Total Assets|ANL - Company Total Assets|Company Total Assets Veru Inc.|Total Business Assets tempesttx.com|XLO - Cumulative Company Assets|Aggregate Asset Value Enochian BioSciences|MURA (Mural Oncology plc) - Company Total Assets|Company Total Asset Base KAPA (kairospharma.com)|OKUR - Aggregate Company Assets|Total Business Assets CytoMed Therapeutics Ltd GDTC|CRIS: Company Total Assets|Apollomics, Inc. (APLM) - Cumulative Company Assets|Tharimmune Corp - Cumulative Company Assets|Advanced Biomed (ADVB) - Company Total Asset Base|GNPX: Company Total Assets|Company Total Asset Base Calidi Bio|Company Total Assets SBFM (Sunshine Biopharma, Inc.)|Cumulative Company Assets xeneticbio.com (XBIO)|Company Total Assets SLRX (Salarius)|Company Total Assets Kitov Pharma PPBT|AON (AONC) - Company Total Assets|BGNE - Total Business Assets|CKPT (Checkpoint Therapeutics, Inc.) - Company Total Assets|elevationoncology.com (ELEV) - Cumulative Company Assets|IKNA (Ikena Oncology Inc.) - Company Total Assets|Company Total Assets NTBL|Aggregate Company Assets Viracta Therapeutics VIRX|Total Business Assets morphosys.com (MOR)|NAYA Biosciences Inc. - Company Total Assets|Cumulative Company Assets Ascentage Pharma Group International AAPGV